Document is current
Any future updates will be listed below
-
Authors
Chao, Bonnie T. https://orcid.org/0000-0001-6067-2931
Sage, Andrew T.
McInnis, Micheal C. https://orcid.org/0000-0002-5725-3258
Ma, Jun
Grubert Van Iderstine, Micah https://orcid.org/0000-0002-4869-2400
Zhou, Xuanzi
Valero, Jerome
Cypel, Marcelo
Liu, Mingyao https://orcid.org/0000-0002-9188-8417
Wang, Bo
Keshavjee, Shaf
-
Funding
Funding for this research was provided by:
University Health Network
University of Toronto
Temerty Centre for AI Research and Education in Medicine at University of Toronto
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 15 September 2024
First Online: 3 October 2024
Competing interests
: Keshavjee serves as Chief Medical Officer of Traferox Technologies and reports personal fees from Lung Bioengineering, outside the submitted work. A.T.S., M.C.M., M.C., B.W., and S.K. declare ongoing patent applications with University Health Network (No.US63/314,930 & No. US63/315,042) related to machine learning models for ex vivo perfusion used in this study. The investigators fully adhere to policies at University Health Network that ensure academic integrity and management of potential conflicts of interest. B.T.C., J.M., M.G.V.I., X.Z., J.V., M.L. declare no competing interests.
